medigraphic.com
Colegio de Medicina Interna de México.

2010, Number 5

<< Back Next >>

Med Int Mex 2010; 26 (5)

Acquired-Community Pneumonia. Validation of a prognostic instrument in a mexican cohort

Galindo-Sainz J, Tejada GRA, Hanssen CF, Jiménez JMO

Language: Spanish
References: 21
Page: 457-461
PDF size: 194.25 Kb.


ABSTRACT

Background: The use of the Pneumonia Severity Index (PSI) has been used as an objective instrument to stratify the risk class of the Community-Acquired Pneumonia (CAP), and in this way determinate if a patient should be hospitalized or treat as an outpatient. In this study we intended to use it in our patients and validate it´s application.
Material and methods: This is a prospective, longitudinal, analytic and observational study, with all the patients with the diagnostic of CAP admitted to our hospital. The PSI was used to evaluate the severity of pneumonia. We followed the progress until the hospital dischart.
Results: We cases of CAP were reported. The medium hospital days were 7.76 ± 5.3. Three percent of the patients had severity grade I, 13% grade II, 43% grade III, 43% grade IV and 33% grade V. Seven deaths were reported, 100% of them were on severity grade IV and V.
Conclusions: The patients with severity grade I,II and III, could be dischart and treat has outpatients with relative security, on the other hand, patients with severity grade IV y V should be admitted to medical treatment for the risk of mortality.


REFERENCES

  1. Sánchez-Hernández V, González-López M, Quintero-Aguirre RP. Factores de riesgo en el adulto mayor en neumonía adquirida en la comunidad. Rev Med IMSS 2002;40(5):387-392.

  2. Bartlett JG, Dowell SF, Mandel LA, et al. Guidelines from the Infectious Diseases Society of America. Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults. CID 2000;31:347-382.

  3. Mandel LA, Bartlett JG, Dowell SF, et al. Update of Practice Guidelines for the Management of Community-Acquired Penumonia in Immunocompetent Adults. CID 2003;37:1405-1433.

  4. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-250.

  5. Metlay JP, Fine MJ. Testing strategies in the initial management of patients with community-acquired pneumonia. Ann Intern Med 2003;138:109-118.

  6. Halm EA, Teirstein AS. Clinical practice. Management of community- acquired pneumonia. N Engl J Med 2002;347:2039-2045.

  7. Campbell SG, Patrick W, Urquhart DG, et al. Patients with community acquired penuemonia discharged from the emergency department according to a clinical practice guideline. Emerg Med J 2004;21:667-669.

  8. Dean NC. Use of prognostic scoring and outcome assessment tools in the admission decision for community-acquired pneumonia. Clin Chest Med 1999;20:521-529.

  9. Coley CM, Li YH, Medsger AR, et al. Preferences for home vs hospital care among low-risk patients with community acquired pneumonia. Arch Intern Med 1996;156:1565-1571.

  10. Suchyta MR, Dean NC, Narus S, Hadlock CJ. Effects of a practice guideline for community-acquired pneumonia in an outpatient setting. Am J Med 2001;110:306-309.

  11. Marrie TJ, Lau CY, Wheeler Sl, et al. A controlled trial of a critic al pathway for treatment of community-acquired pneumonia. JAMA 2000;283:749-755.

  12. Halm EA, Atlas SJ, Borowsky LH, et al. Change in physician knowledge and attitudes after implementation of a pneumonia practice guideline. J Gen Intern Med 1999;14:688-694.

  13. Coley CM, Li YH, Medsger AR, et al. Preferences for home vs hospital care among low-risk patients with communityacquired pneumonia. Arch Intern Med 1996;156:1565-1571.

  14. De Roux A, Cavalcanti M, Marcos MA, et al. CHEST 2006;129:1219-1225.

  15. Castillo-Sánchez DL, Sabag-Ruiz E, Díaz-Verduzco MJ, Monzón-Vega MA. Neumonía adquirida en la comunidad. Enfoque de riesgo y funcionalidad familiar . Rev Med Inst Seguro Soc 2006;44(1):35-38.

  16. McAlister FA, Majumdar SR, Blitz S, et al. The Relation Between Hyperglycemia and Outcomes in 2,471 Patients Admitted to the Hospital With Community-Acquired Pneumonia. Diabetes Care 2005;28:810-815.

  17. Falguera M, Pifarre R, Martin A, et al. Etiology and Outcome of Community-Acquired Pneumonia in Patients With Diabetes Mellitus. CHEST 2005;128:3233-3239.

  18. Fisman DN, Abrutyn E, Spaude KA, et al. Prior Pneumococcal Vaccination Is Associated with Reduced Death, Complications, and Length of Stay among Hospitalized Adults with Community- Acquired Pneumonia. CID 2006;42:1093-1101.

  19. Mandell LA, Wunderink RG, Anzuelo A, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. CID 2007;44:S27-72.




2020     |     www.medigraphic.com